{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:42:44Z","timestamp":1760060564608,"version":"build-2065373602"},"reference-count":98,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background: Amyotrophic Lateral Sclerosis (ALS) is a heterogeneous neurodegenerative disorder with highly variable progression and survival. Identifying early prognostic indicators is essential for patient stratification and management. Objectives: To evaluate clinical, respiratory, and functional predictors of survival in a prospective cohort of ALS patients over a three-year period. Methods: A cohort of 44 ALS patients was followed from 2022 to 2025. Demographic and anthropometric characteristics, clinical data including ALS subtypes and phenotypes, site of onset, revised ALS functional rating scale (ALSFRS-R) and subscores, ALSFRS-R progression rate, time to diffusion and generalization, spirometric parameters, and progression patterns were assessed. Survival analysis was performed using Kaplan\u2013Meier estimates and univariate and multivariate Cox proportional hazard regression analysis. Results: The overall median survival time was 53 months. Univariate Cox regression revealed that older age at onset, shorter diagnostic delay, lower respiratory function, lower vitamin D levels, and rapid vertical progression were associated with reduced survival. Bulbar-onset phenotype and rapid disease progression rate (\u0394PR) were significant predictors of mortality. Specific ALSFRS-R subscores also showed prognostic relevance. A longer time to diffusion as well as a longer time to generalization were significantly associated with prolonged survival. Multivariate analysis confirmed the independent prognostic value of \u0394PR, time to diagnosis, and ALSFRS-R swallowing and handwriting subscores. Conclusions: This study supports the prognostic value of previously studied clinical and paraclinical markers in ALS and proposes novel predictors, ALSFRS-R handwriting, and time to diffusion, which require further validation in larger prospective cohorts.<\/jats:p>","DOI":"10.3390\/medsci13030170","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:07:32Z","timestamp":1756901252000},"page":"170","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Paraclinical Predictors of Survival in Amyotrophic Lateral Sclerosis: Results from a Three-Year Longitudinal Cohort Study"],"prefix":"10.3390","volume":"13","author":[{"given":"Anca","family":"Motataianu","sequence":"first","affiliation":[{"name":"Neurology Department, University of Medicine, Pharmacy, Science and Technology \u201cGeorge Emil Palade\u201d Targu Mures, Gh. Marinescu Str., No. 38, Mures, 540142 Targu Mures, Romania"},{"name":"Neurology 1 Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Barcutean","sequence":"additional","affiliation":[{"name":"Neurology Department, University of Medicine, Pharmacy, Science and Technology \u201cGeorge Emil Palade\u201d Targu Mures, Gh. Marinescu Str., No. 38, Mures, 540142 Targu Mures, Romania"},{"name":"Neurology 1 Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana","family":"Ormenisan","sequence":"additional","affiliation":[{"name":"Neurology 1 Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medeea","family":"Roman","sequence":"additional","affiliation":[{"name":"Neurology 1 Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodica","family":"Balasa","sequence":"additional","affiliation":[{"name":"Neurology Department, University of Medicine, Pharmacy, Science and Technology \u201cGeorge Emil Palade\u201d Targu Mures, Gh. Marinescu Str., No. 38, Mures, 540142 Targu Mures, Romania"},{"name":"Neurology 1 Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoltan","family":"Bajko","sequence":"additional","affiliation":[{"name":"Neurology Department, University of Medicine, Pharmacy, Science and Technology \u201cGeorge Emil Palade\u201d Targu Mures, Gh. Marinescu Str., No. 38, Mures, 540142 Targu Mures, Romania"},{"name":"Neurology 1 Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Dumitreasa","sequence":"additional","affiliation":[{"name":"Neurology 1 Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"105456","DOI":"10.1016\/j.clineuro.2019.105456","article-title":"The Prognostic Value of Spirometric Tests in Amyotrophic Lateral Sclerosis Patients","volume":"184","author":"Pirola","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Vidovic, M., M\u00fcschen, L.H., Brakemeier, S., Machetanz, G., Naumann, M., and Castro-Gomez, S. (2023). Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis. Cells, 12.","DOI":"10.3390\/cells12050736"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/14660820410021311","article-title":"Survival of 793 Patients with Amyotrophic Lateral Sclerosis Diagnosed over a 28-Year Period","volume":"5","author":"Testa","year":"2004","journal-title":"Amyotroph. Lateral Scler. Mot. Neuron Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2399962","DOI":"10.1080\/07853890.2024.2399962","article-title":"Clinical Features and Progress in Diagnosis and Treatment of Amyotrophic Lateral Sclerosis","volume":"56","author":"Yuan","year":"2024","journal-title":"Ann. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","article-title":"Prognosis for Patients with Amyotrophic Lateral Sclerosis: Development and Validation of a Personalised Prediction Model","volume":"17","author":"Westeneng","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1802237","DOI":"10.1183\/13993003.02237-2018","article-title":"Development of a Prognostic Model of Respiratory Insufficiency or Death in Amyotrophic Lateral Sclerosis","volume":"53","author":"Ackrivo","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Benatar, M., Macklin, E.A., Malaspina, A., Rogers, M.-L., Hornstein, E., Lombardi, V., Renfrey, D., Shepheard, S., Magen, I., and Cohen, Y. (2024). Prognostic Clinical and Biological Markers for Amyotrophic Lateral Sclerosis Disease Progression: Validation and Implications for Clinical Trial Design and Analysis. eBioMedicine, 108.","DOI":"10.1016\/j.ebiom.2024.105323"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic Heterogeneity of Amyotrophic Lateral Sclerosis: A Population Based Study","volume":"82","author":"Calvo","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","article-title":"Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)","volume":"7","author":"Grad","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/mus.24198","article-title":"Genetic Heterogeneity of Amyotrophic Lateral Sclerosis: Implications for Clinical Practice and Research","volume":"49","author":"Su","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00415-016-8313-y","article-title":"Factors Predicting Survival in ALS: A Multicenter Italian Study","volume":"264","author":"Calvo","year":"2017","journal-title":"J. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jnnp.2007.118018","article-title":"Analysis of Survival and Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population Based Study","volume":"79","author":"Zoccolella","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/mus.20450","article-title":"Pulmonary Predictors of Survival in Amyotrophic Lateral Sclerosis: Use in Clinical Trial Design","volume":"33","author":"Schmidt","year":"2006","journal-title":"Muscle Nerve"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/17482960902991773","article-title":"Use of Respiratory Function Tests to Predict Survival in Amyotrophic Lateral Sclerosis","volume":"11","author":"Baumann","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Verde, F., Otto, M., and Silani, V. (2021). Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.679199"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tzeplaeff, L., J\u00fcrs, A.V., Wohnrade, C., and Demleitner, A.F. (2024). Unraveling the Heterogeneity of ALS-A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials. Cells, 13.","DOI":"10.3390\/cells13050452"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneurol.2012.254","article-title":"Awaji Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis:A Systematic Review","volume":"69","author":"Costa","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_18","first-page":"293","article-title":"El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp-2015-310998","article-title":"Rate of Disease Progression: A Prognostic Biomarker in ALS","volume":"87","author":"Labra","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \u201cClinical Limits of Amyotrophic Lateral Sclerosis\u201d Workshop Contributors","volume":"124","author":"Brooks","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"ref_21","unstructured":"NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US) (2025, July 01). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK2003\/."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: A Revised ALS Functional Rating Scale That Incorporates Assessments of Respiratory Function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/21678421.2013.778548","article-title":"Deciphering Amyotrophic Lateral Sclerosis: What Phenotype, Neuropathology and Genetics Are Telling Us about Pathogenesis","volume":"14","author":"Ravits","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2899","DOI":"10.1002\/brb3.2899","article-title":"Different Patterns of Spreading Direction and Motor Neurons Involvement in a Cohort of Limb-onset Amyotrophic Lateral Sclerosis Patients from Southern Italy: Potential Implication on Disease Course or Progression?","volume":"13","author":"Milella","year":"2023","journal-title":"Brain Behav."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: A Frontal Assessment Battery at Bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10072-005-0443-4","article-title":"The Frontal Assessment Battery (FAB): Normative Values in an Italian Population Sample","volume":"26","author":"Appollonio","year":"2005","journal-title":"Neurol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J. Pers. Assess."},{"key":"ref_28","first-page":"129","article-title":"Pulmonary Function in Patients with Amyotrophic Lateral Sclerosis at Disease Onset","volume":"77","author":"Chandrasoma","year":"2012","journal-title":"Monaldi Arch. Chest Dis. Arch. Monaldi Mal. Torace"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"230043","DOI":"10.1183\/20734735.0043-2023","article-title":"Pearls and Pitfalls of Respiratory Testing in a Patient with Amyotrophic Lateral Sclerosis and COPD","volume":"19","author":"Littleton","year":"2023","journal-title":"Breathe Sheff. Engl."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.26933","article-title":"Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis","volume":"96","author":"Grassano","year":"2024","journal-title":"Ann. Neurol."},{"key":"ref_31","first-page":"e802","article-title":"ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study","volume":"94","author":"Moglia","year":"2020","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/21678421.2024.2315185","article-title":"Rurality Modifies the Association between Symptoms and the Diagnosis of Amyotrophic Lateral Sclerosis","volume":"25","author":"Hart","year":"2024","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.14336\/AD.2018.0327","article-title":"Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population","volume":"10","author":"Korner","year":"2019","journal-title":"Aging Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e16464","DOI":"10.1111\/ene.16464","article-title":"Croplands Proximity Is Associated with Amyotrophic Lateral Sclerosis Incidence and Age at Onset","volume":"32","author":"Manera","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jocn.2019.05.036","article-title":"Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in China","volume":"66","author":"Lian","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhu, Q., Zhou, J., Zhang, Y., Huang, H., Han, J., Cao, B., Xu, D., Zhao, Y., and Chen, G. (2023). Risk Factors Associated with Amyotrophic Lateral Sclerosis Based on the Observational Study: A Systematic Review and Meta-Analysis. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1196722"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/ina.12375","article-title":"Building Dampness and Mold in European Homes in Relation to Climate, Building Characteristics and Socio-Economic Status: The European Community Respiratory Health Survey ECRHS II","volume":"27","author":"Zock","year":"2017","journal-title":"Indoor Air"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.shaw.2020.01.003","article-title":"Moist and Mold Exposure Is Associated With High Prevalence of Neurological Symptoms and MCS in a Finnish Hospital Workers Cohort","volume":"11","author":"Lohi","year":"2020","journal-title":"Saf. Health Work"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kj\u00e6ldgaard, A.L., Pilely, K., Olsen, K.S., Jessen, A.H., Lauritsen, A.\u00d8., Pedersen, S.W., Svenstrup, K., Karlsborg, M., Thagesen, H., and Blaabjerg, M. (2021). Prediction of Survival in Amyotrophic Lateral Sclerosis: A Nationwide, Danish Cohort Study. BMC Neurol., 21.","DOI":"10.1186\/s12883-021-02187-8"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000086353","article-title":"Survival of Patients with Amyotrophic Lateral Sclerosis in a Population-Based Registry","volume":"25","author":"Millul","year":"2005","journal-title":"Neuroepidemiology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1212\/CPJ.0b013e3182a1b8ab","article-title":"Prognosis and Epidemiology of Amyotrophic Lateral Sclerosis: Analysis of a Clinic Population, 1997-2011","volume":"3","author":"Traxinger","year":"2013","journal-title":"Neurol. Clin. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.24096","article-title":"Long-Term Survival in Amyotrophic Lateral Sclerosis: A Population-Based Study","volume":"75","author":"Pupillo","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/21678421.2017.1349151","article-title":"The Benefit of Evolving Multidisciplinary Care in ALS: A Diagnostic Cohort Survival Comparison","volume":"18","author":"Martin","year":"2017","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/21678421.2021.2004167","article-title":"Trends in Survival of ALS from a Population-Based Registry","volume":"23","author":"Bianchi","year":"2022","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e213467","DOI":"10.1212\/WNL.0000000000213467","article-title":"Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995\u20132018)","volume":"104","author":"Vasta","year":"2025","journal-title":"Neurology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature","volume":"41","author":"Logroscino","year":"2013","journal-title":"Neuroepidemiology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Mart\u00ednez, C.M., Chore\u00f1o-Parra, J.A., Nu\u00f1ez-Orozco, L., Placencia-\u00c1lvarez, N., Alvis-Casta\u00f1o, L.M., and Guadarrama-Ortiz, P. (2019). A Retrospective Study of the Clinical Phenotype and Predictors of Survival in Non-Caucasian Hispanic Patients with Amyotrophic Lateral Sclerosis. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1459-3"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wolf, J., Safer, A., W\u00f6hrle, J.C., Palm, F., Nix, W.A., Maschke, M., and Grau, A.J. (2014). Factors Predicting One-Year Mortality in Amyotrophic Lateral Sclerosis Patients\u2014Data from a Population-Based Registry. BMC Neurol., 14.","DOI":"10.1186\/s12883-014-0197-9"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00415-018-8778-y","article-title":"Riluzole and Other Prognostic Factors in ALS: A Population-Based Registry Study in Italy","volume":"265","author":"Mandrioli","year":"2018","journal-title":"J. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Moura, M.C., Novaes, M.R.C.G., Eduardo, E.J., Zago, Y.S.S.P., Freitas, R.D.N.B., and Casulari, L.A. (2015). Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141500"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.mayocpiqo.2024.07.008","article-title":"Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States","volume":"8","author":"Shah","year":"2024","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Su, W.-M., Cheng, Y.-F., Jiang, Z., Duan, Q.-Q., Yang, T.-M., Shang, H.-F., and Chen, Y.-P. (2021). Predictors of Survival in Patients with Amyotrophic Lateral Sclerosis: A Large Meta-Analysis. eBioMedicine, 74.","DOI":"10.1016\/j.ebiom.2021.103732"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Falc\u00e3o de Campos, C., Gromicho, M., Uysal, H., Grosskreutz, J., Kuzma-Kozakiewicz, M., Oliveira Santos, M., Pinto, S., Petri, S., Swash, M., and de Carvalho, M. (2023). Trends in the Diagnostic Delay and Pathway for Amyotrophic Lateral Sclerosis Patients across Different Countries. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.1064619"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Molina, M., Argente-Escrig, H., Polo, M.F., Herv\u00e1s, D., Frasquet, M., Cort\u00e9s, V., Sevilla, T., and V\u00e1zquez-Costa, J.F. (2020). Early Referral to an ALS Center Reduces Several Months the Diagnostic Delay: A Multicenter-Based Study. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.604922"},{"key":"ref_55","first-page":"504","article-title":"Analysis of the Diagnostic Pathway and Delay in Patients with Amyotrophic Lateral Sclerosis in the Valencian Community","volume":"36","year":"2021","journal-title":"Neurologia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1136\/jnnp-2015-312908","article-title":"A Clinical Tool for Predicting Survival in ALS","volume":"87","author":"Knibb","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/ene.15874","article-title":"Diagnostic Delay in Amyotrophic Lateral Sclerosis","volume":"30","author":"Gwathmey","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"117054","DOI":"10.1016\/j.jns.2020.117054","article-title":"Time to Diagnosis and Factors Affecting Diagnostic Delay in Amyotrophic Lateral Sclerosis","volume":"417","author":"Richards","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.neubiorev.2017.01.045","article-title":"The Neuropathological Signature of Bulbar-Onset ALS: A Systematic Review","volume":"75","author":"Shellikeri","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/21678421.2013.763281","article-title":"The Impact of Clinical Factors, Riluzole and Therapeutic Interventions on ALS Survival: A Population Based Study in Modena, Italy","volume":"14","author":"Georgoulopoulou","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kim, H.-J., de Leon, M., Wang, X., Kim, H.Y., Lee, Y.-J., Kim, Y.-H., and Kim, S.H. (2017). Relationship between Clinical Parameters and Brain Structure in Sporadic Amyotrophic Lateral Sclerosis Patients According to Onset Type: A Voxel-Based Morphometric Study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0168424"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/jnnp-2020-322909","article-title":"Prognostic Value of Weight Loss in Patients with Amyotrophic Lateral Sclerosis: A Population-Based Study","volume":"91","author":"Tan","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/acn3.51098","article-title":"Spreading in ALS: The Relative Impact of Upper and Lower Motor Neuron Involvement","volume":"7","author":"Gromicho","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/21678421.2022.2164205","article-title":"The Flail-Arm Syndrome: The Influence of Phenotypic Features","volume":"24","author":"Gromicho","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Colombo, E., Gentile, F., Maranzano, A., Doretti, A., Verde, F., Olivero, M., Gagliardi, D., Far\u00e9, M., Meneri, M., and Poletti, B. (2023). The Impact of Upper Motor Neuron Involvement on Clinical Features, Disease Progression and Prognosis in Amyotrophic Lateral Sclerosis. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1249429"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/21678421.2015.1125502","article-title":"Targeted Assessment of Lower Motor Neuron Burden Is Associated with Survival in Amyotrophic Lateral Sclerosis","volume":"17","author":"Devine","year":"2016","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1093\/brain\/awad129","article-title":"Regional Spreading Pattern Is Associated with Clinical Phenotype in Amyotrophic Lateral Sclerosis","volume":"146","author":"Maranzano","year":"2023","journal-title":"Brain J. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/21678421.2017.1386688","article-title":"Patterns of Symptom Development in Patients with Motor Neuron Disease","volume":"19","author":"Walhout","year":"2018","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1468-1331.2011.03616.x","article-title":"Regional Spread Pattern Predicts Survival in Patients with Sporadic Amyotrophic Lateral Sclerosis","volume":"19","author":"Janota","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/ene.12994","article-title":"Time to Generalization and Prediction of Survival in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Observational Study","volume":"23","author":"Tortelli","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/CM9.0000000000000200","article-title":"Prognostic Value of Time to Generalization in 71 Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis","volume":"132","author":"Sun","year":"2019","journal-title":"Chin. Med. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression Rate of ALSFRS-R at Time of Diagnosis Predicts Survival Time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s10072-015-2343-6","article-title":"Heterogeneity in ALSFRS-R Decline and Survival: A Population-Based Study in Italy","volume":"36","author":"Mandrioli","year":"2015","journal-title":"Neurol. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/21678421.2014.993650","article-title":"The Predictors of Survival in Chinese Amyotrophic Lateral Sclerosis Patients","volume":"16","author":"Wei","year":"2015","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4274\/tod.galenos.2024.37880","article-title":"Vitamin D Levels and Their Relationship with Ambulation in Patients with Amyotrophic Lateral Sclerosis","volume":"30","author":"Sertpoyraz","year":"2024","journal-title":"Turk. J. Osteoporos."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s10072-023-06751-7","article-title":"Potential Role of Vitamin D Levels in Amyotrophic Lateral Sclerosis Cognitive Impairment","volume":"44","author":"Saraceno","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Juntas-Morales, R., Pageot, N., Marin, G., Dupuy, A.-M., Alphandery, S., Labar, L., Esselin, F., Picot, M.C., and Camu, W. (2020). Low 25OH Vitamin D Blood Levels Are Independently Associated With Higher Amyotrophic Lateral Sclerosis Severity Scores: Results From a Prospective Study. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00363"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neurobiolaging.2013.11.005","article-title":"Vitamin D Confers Protection to Motoneurons and Is a Prognostic Factor of Amyotrophic Lateral Sclerosis","volume":"35","author":"Camu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/cns.12423","article-title":"Vitamin D Is Not a Protective Factor in ALS","volume":"21","author":"Blasco","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2016.05.007","article-title":"Vitamin D Levels Are Not Predictors of Survival in a Clinic Population of Patients with ALS","volume":"367","author":"Yang","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Lanznaster, D., Bejan-Angoulvant, T., Gand\u00eda, J., Blasco, H., and Corcia, P. (2020). Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00697"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1212\/WNL.0000000000208244","article-title":"Value of FVC and Its Rate of Decline for Predicting Survival in ALS (S5.005)","volume":"102","author":"Seyam","year":"2024","journal-title":"Neurology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/jnnp.2005.072660","article-title":"Forced Vital Capacity (FVC) as an Indicator of Survival and Disease Progression in an ALS Clinic Population","volume":"77","author":"Czaplinski","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_84","first-page":"e54176","article-title":"Forced Expiratory Volume in One Second Quotient (FEV1Q) as a Prognostic Factor in Amyotrophic Lateral Sclerosis Patients: Comparing Its Predictive Value to Other Lung Function Measurements","volume":"16","author":"Barroso","year":"2024","journal-title":"Cureus"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Zhang, Q.-J., Huang, J.-C., Chen, J., Hu, W., Xu, L.-Q., and Guo, Q.-F. (2022). Peak Expiratory Flow Is a Reliably Household Pulmonary Function Parameter Correlates with Disease Severity and Survival of Patients with Amyotrophic Lateral Sclerosis. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02635-z"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Orlova, A., Malygin, Y., Gofman, A., Sotulenko, S., Gandalian, V., Kartashov, I., Brylev, L., Bolevich, S., Nikolic Turnic, T., and Jakovljevic, V. (2024). Survival Prognostic Factors of Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A Systematic Review. Life, 14.","DOI":"10.3390\/life14121664"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/CPJ.0000000000000521","article-title":"Body Mass Index and Survival from Amyotrophic Lateral Sclerosis: A Meta-Analysis","volume":"8","author":"Dardiotis","year":"2018","journal-title":"Neurol. Clin. Pract."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.02.035","article-title":"Body Mass Index and Dietary Intervention: Implications for Prognosis of Amyotrophic Lateral Sclerosis","volume":"340","author":"Ngo","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","article-title":"Life Course Body Mass Index and Risk and Prognosis of Amyotrophic Lateral Sclerosis: Results from the ALS Registry Swabia","volume":"32","author":"Peter","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/17482968.2012.678366","article-title":"Reduction Rate of Body Mass Index Predicts Prognosis for Survival in Amyotrophic Lateral Sclerosis: A Multicenter Study in Japan","volume":"13","author":"Shimizu","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Nakamura, R., Kurihara, M., Kobashi, S., Tamaki, Y., Ogawa, N., Kitamura, A., Yamakawa, I., Bamba, S., Terashima, T., and Urushitani, M. (2023). Ideal Body Weight-Based Determination of Minimum Oral Calories Beneficial to Function and Survival in ALS. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1286153"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1378\/chest.06-2712","article-title":"The Amyotrophic Lateral Sclerosis Functional Rating Scale Predicts Survival Time in Amyotrophic Lateral Sclerosis Patients on Invasive Mechanical Ventilation","volume":"132","author":"Marchese","year":"2007","journal-title":"Chest"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1212\/01.WNL.0000148648.38313.64","article-title":"The ALSFRSr Predicts Survival Time in an ALS Clinic Population","volume":"64","author":"Kaufmann","year":"2005","journal-title":"Neurology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1007\/s00415-023-11832-w","article-title":"Autonomic Dysfunction Is Associated with Disease Progression and Survival in Amyotrophic Lateral Sclerosis: A Prospective Longitudinal Cohort Study","volume":"270","author":"Dubbioso","year":"2023","journal-title":"J. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"P4.094","DOI":"10.1212\/WNL.82.10_supplement.P4.094","article-title":"Subscales of the ALS Functional Rating Scale (ALSFRS-R) as Determinants of Survival in Amyotrophic Lateral Sclerosis (ALS) (P4.094)","volume":"82","author":"Rascovsky","year":"2014","journal-title":"Neurology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp-2016-314661","article-title":"What Does the ALSFRS-R Really Measure? A Longitudinal and Survival Analysis of Functional Dimension Subscores in Amyotrophic Lateral Sclerosis","volume":"88","author":"Rooney","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","article-title":"Respiratory Failure in Amyotrophic Lateral Sclerosis","volume":"155","author":"Niedermeyer","year":"2019","journal-title":"Chest"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1212\/WNL.0000000000007776","article-title":"Variation in Noninvasive Ventilation Use in Amyotrophic Lateral Sclerosis","volume":"93","author":"Thakore","year":"2019","journal-title":"Neurology"}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/3\/170\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:38:46Z","timestamp":1760035126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/3\/170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":98,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medsci13030170"],"URL":"https:\/\/doi.org\/10.3390\/medsci13030170","relation":{},"ISSN":["2076-3271"],"issn-type":[{"type":"electronic","value":"2076-3271"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}